Protagenic Therapeutics, Inc.new PTIX
OTC PTIX
$0.47 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST

Protagenic Therapeutics, Inc.new (PTIX) Gross Margin (2010 - 2011)

Updated

Protagenic Therapeutics, Inc.new (PTIX) recorded Gross Margin of 79.75% in fiscal Q3 2013 (quarter ended Sep 30, 2011), up 35.87 percentage points from the prior quarter.

Analysis

Protagenic Therapeutics, Inc.new (PTIX) Gross Margin (2010 - 2011) Analysis & Trends

On a TTM basis, Protagenic Therapeutics, Inc.new's Gross Margin came in at 77.69% as of Sep 30, 2011.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,305.71 Bn 1,279.33 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 694.23 Bn 614.09 Bn 17.30 Bn 68.12%
3 AbbVie 528.96 Bn 496.97 Bn 13.12 Bn 75.38%
4 Merck 365.92 Bn 328.86 Bn 13.19 Bn 72.95%
5 Novartis Ag 314.95 Bn 288.19 Bn - -
6 Astrazeneca 289.15 Bn 262.67 Bn 13.26 Bn 88.03%
7 Amgen 254.11 Bn 205.76 Bn 7.58 Bn 73.10%
8 Gilead Sciences 211.85 Bn 186.96 Bn 6.73 Bn 81.07%
9 Pfizer 165.73 Bn 113.09 Bn 12.56 Bn 75.71%
10 Protagenic Therapeutics, Inc.new 850,797.76 -3.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2011 79.75%
Jun 30, 2011 43.88%
Mar 31, 2011 50.69%
Sep 30, 2010 53.57%
Jun 30, 2010 53.84%
Mar 31, 2010 50.97%
API Access

Protagenic Therapeutics, Inc.new Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=PTIX&period=max&api_key=YOUR_API_KEY